Is oncology pharma a good stock to buy now?
The current Oncology Pharma [ONPH] share price is $2.00. The Score for ONPH is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. ONPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Is Oncology a buy?
ALX Oncology has received a consensus rating of Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.
Who owns oncology pharma?
Marcel van HeesewijkDescription Oncology Pharma Inc. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
Will oncology pharma stock go up?
The price has fallen in 6 of the last 10 days and is down by -11.36% for this period. Volume has increased on the last day by 42 thousand shares but on falling prices....Predicted Opening Price for Oncology Pharma Inc. of Wednesday, June 1, 2022.Fair opening price June 1, 2022Current price$1.98$1.95 (Undervalued)
Does oncology pharma pay dividends?
ONPH does not currently pay a dividend.
What does Oncology Pharma do?
Oncology Pharma Inc. operates as an oncology company. The Company focuses on developing, manufacturing, and commercialization of therapeutics for cancer patients. Oncology Pharma provides antinuclear antibody that targets areas of necrosis present in solid tumors.
What does ONPH company do?
ABOUT ONCOLOGY PHARMA, INC. (OTC PINK:ONPH) (the 'Company') is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
What oncology means?
Listen to pronunciation. (on-KAH-loh-jee) A branch of medicine that specializes in the diagnosis and treatment of cancer.
Is Clvs a good stock to buy?
The financial health and growth prospects of CLVS, demonstrate its potential to underperform the market. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors.
Is ONPH a good stock to buy now?
If you are looking for stocks with good return, Oncology Pharma Inc stock can be a bad, high-risk 1-year investment option. Oncology Pharma Inc real time quote is equal to 2.000 USD at 2022-06-02, but your current investment may be devalued in the future. Get It Now!
What stock is TaaS?
A TaaS stock is a financial asset sold by a public company within the TaaS industry, such as Uber (NYSE: UBER), Lift (NYSE: LYFT), Yandex (NYSE: YNDX), or Dominos Pizza (NYSE: DPZ).
Is ONPH a buy Zacks?
See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy25.08%2Buy18.56%3Hold10.15%4Sell5.79%2 more rows